Intranasal sufentanil-ketamine appears safe, effective for pediatric acute pain

AI Summary

A study presented at the European Emergency Medicine Congress found that intranasal sufentanil-ketamine appeared fast-acting, well tolerated, and effective for acute pain in pediatric emergency patients. The congress took place in Paris from September 23–27.

Intranasal sufentanil-ketamine is fast-acting and appears to be well tolerated and effective at curbing acute pain for pediatric patients in the emergency department, according to a study presented at the annual European Emergency Medicine Congress, held Sept. 23–27 in Paris.